Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
about
PINP as a biological response marker during teriparatide treatment for osteoporosisA phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis.Serum bone biomarkers and oral/systemic bone loss in humansEffects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational StudyA fracture does not adversely affect bone mineral density responses after teriparatide treatmentCorrelations Between Abnormal Glucose Metabolism and Bone Mineral Density or Bone MetabolismTeriparatide for idiopathic osteoporosis in premenopausal women: a pilot study.Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report.Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosisSignificant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.Bone Mineral Density Response from Teriparatide in Patients with Osteoporosis.Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease.A Longitudinal Study of Skeletal Histomorphometry at 6 and 24 Months Across Four Bone Envelopes in Postmenopausal Women With Osteoporosis Receiving Teriparatide or Zoledronic Acid in the SHOTZ Trial.The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club.Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis.Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.A retrospective analysis of nonresponse to daily teriparatide treatment.Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis.Serum undercarboxylated osteocalcin level increases with 48 weeks of teriparatide treatment in pre-treated elderly rheumatoid arthritis patients who use anti-resorptive drugs.Bone Turnover Status: Classification Model and Clinical Implications.Influence of Dosing Interval and Administration on the Bone Metabolism, Skeletal Effects, and Clinical Efficacy of Parathyroid Hormone in Treating Osteoporosis: A Narrative Review
P2860
Q26859267-35DC37DC-65DC-4F00-B914-B35012BD499DQ33570177-70D94EAC-6C94-4D8E-8915-9F42E33EA4EEQ34975430-5874847A-3405-4B68-95CE-718E61095558Q35598005-230B1B76-B1FF-4423-80F9-F1D0EE3C9A40Q35723052-8060B43D-208D-4D2C-B225-6726FC03518BQ36691678-449B6A73-1EE4-4256-BD4F-0D154279C33EQ36817240-C4AD9661-A077-4352-961A-F17B3024911EQ37082771-B69AA280-EE2F-436A-9909-783CB595F4B1Q37337557-A2753FC9-24B5-4563-B05B-A8B4CCA96156Q37609131-BC4D03DB-61D3-4F23-BDF4-A4168CEC889BQ38687469-1CB3D90B-E0E7-41AC-BBC8-DEEB02BE8C9CQ39035413-2221D1AF-881D-4B9D-8ACB-583A828DE579Q40027774-BFCDA859-A004-4D0E-98D9-0EBE75B56340Q40828040-5909542B-ED61-4004-AF1D-9BCF2489BEEDQ46583319-602997CC-5436-49FE-AA3B-F4E08284BC5BQ48160184-5AA94469-B1E2-4DA7-8265-8F2F6E8E1CBBQ50911376-E59DF274-3B05-4AA5-A413-9462A824A586Q51283005-4554A936-A37B-4AD4-B60F-72C80D39D1E1Q51297902-C3FD5319-00CC-4DA5-8E18-84B511B29CB4Q55002406-08E981E2-9CD7-4E6A-96E3-78B618B3B165Q57153285-C7AB498F-7E64-4BB5-A2FF-E499E3151793
P2860
Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatide
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Early changes in biochemical m ...... of treatment with teriparatide
@ast
Early changes in biochemical m ...... of treatment with teriparatide
@en
Early changes in biochemical m ...... of treatment with teriparatide
@nl
type
label
Early changes in biochemical m ...... of treatment with teriparatide
@ast
Early changes in biochemical m ...... of treatment with teriparatide
@en
Early changes in biochemical m ...... of treatment with teriparatide
@nl
prefLabel
Early changes in biochemical m ...... of treatment with teriparatide
@ast
Early changes in biochemical m ...... of treatment with teriparatide
@en
Early changes in biochemical m ...... of treatment with teriparatide
@nl
P2093
P2860
P1476
Early changes in biochemical m ...... of treatment with teriparatide
@en
P2093
A Blumsohn
EUROFORS Study Group
G Sigurdsson
J González de la Vera
S Liu-Léage
T Nickelsen
P2860
P2888
P304
P356
10.1007/S00198-010-1379-Y
P407
P577
2010-10-12T00:00:00Z